Psyence Biomedical Income Statement (2023-2025) | PBM

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2023	Mar2024	Sep2024	Mar2025	Sep2025
Revenue & cost
Cost of Revenue (Quarter)			0.00B		0.00B
Operating items
Research & Development (Quarter)			0.00B		0.00B
Selling, General & Administrative (Quarter)			0.00B		0.00B
Operating Expenses (Quarter)			0.00B		0.00B
EBIT (Quarter)	-0.00B		0.00B		-0.00B
Non-operating items
Interest & Investment Income (Quarter)					0.00B
Other Non Operating Income (Quarter)			0.00B		257.00
Net income details
EBT (Quarter)	-0.00B		0.00B		-0.00B
Profit After Tax (Quarter)	-0.00B		0.00B		-0.00B
Income from Continuing Operations (Quarter)	-0.00B		0.00B		-0.00B
Consolidated Net Income (Quarter)	-0.00B		0.00B		-0.00B
Income towards Parent Company (Quarter)	-0.00B		0.00B		-0.00B
Net Income towards Common Stockholders (Quarter)	-0.00B		0.00B		-0.00B
Additional items
EPS (Basic) (Quarter)	-0.07		0.28		0.00
EPS (Weighted Average and Diluted) (Quarter)	-0.07		0.03		0.00
Shares Outstanding (Weighted Average) (Quarter)	0.05B	0.01B	0.00B	61.75B	68.88B
Shares Outstanding (Diluted Average) (Quarter)	0.05B	0.00B	0.03B		1.48B
EBITDA (Quarter)	-0.00B		0.00B		-0.00B
Interest Expenses (Quarter)			0.00B		-0.00B